← Open Payments lookup

DEBRA GRAHAM: Open Payments

NPI 1790757623 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,994 in 90 payments from 11 companies in 2025. Trend: 2023 $344 · 2024 $953 · 2025 $1,994

Food & beverage: $1,900Education: $94
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.32$631
Teva Pharmaceuticals USA, Inc.14$385
Alkermes, Inc.15$244
Vanda Pharmaceuticals Inc.8$231
ABBVIE INC.5$114
Otsuka America Pharmaceutical, Inc.5$112
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$97
Lundbeck LLC3$72
Axsome Therapeutics, Inc.3$53
Janssen Pharmaceuticals, Inc1$35

Products named: INGREZZA, UZEDY, FANAPT, ARISTADA, REXULTI, VRAYLAR, CAPLYTA, Auvelity.

Industry payments across CA — which companies pay providers there.